Gestational edema with proteinuria, unspecified trimester
ICD-10 O12.20 is a billable code used to indicate a diagnosis of gestational edema with proteinuria, unspecified trimester.
Gestational edema with proteinuria, unspecified trimester, refers to the accumulation of excess fluid in the tissues of a pregnant woman, accompanied by the presence of protein in the urine. This condition typically arises during pregnancy and can be indicative of underlying issues, although it is not associated with hypertension in this specific code. Gestational edema can occur at any stage of pregnancy and may be a normal physiological response to the increased blood volume and fluid retention that occurs during this time. However, when proteinuria is present, it raises concerns for potential complications, such as gestational hypertension or preeclampsia, even if hypertension is not currently diagnosed. Accurate identification and coding of this condition are crucial for monitoring maternal and fetal health, as well as for appropriate management and intervention strategies. Clinicians must carefully document the presence of edema and proteinuria, including the timing of onset and any associated symptoms, to ensure proper coding and management.
Detailed documentation of symptoms, timing, and clinical findings related to edema and proteinuria.
Routine prenatal visits where edema is noted, and urine tests reveal proteinuria.
Consideration of the patient's overall health, history of hypertension, and any other comorbidities.
Comprehensive documentation of high-risk factors, including maternal history and fetal monitoring.
Management of patients with multiple risk factors for preeclampsia or other complications.
In-depth evaluation of maternal and fetal health, with a focus on potential complications.
Used to evaluate proteinuria in pregnant patients presenting with edema.
Documentation of urinalysis results and clinical findings related to edema.
Obstetricians should ensure that urinalysis is performed in conjunction with routine prenatal care.
To support the use of O12.20, documentation should include the presence of edema, results of urine tests indicating proteinuria, and the absence of hypertension. Additionally, any relevant clinical findings and management plans should be clearly recorded.
